Abstract
Helicobacter pylori infection is a pre-MALT lymphoma condition. H pylori eradication leads to complete remission in 80% of low grade stage E1 lymphomas, with a yearly recurrence rate of approximately 5%. The possibility for complete remission in high grade lymphomas needs to be investigated in prospective studies. In addition, the significance of persistent B cell monoclonality (stable disease? danger of relapse? regression of monoclonality?) needs to be investigated in follow up studies.
MeSH terms
-
Animals
-
Biopsy
-
Disease Progression
-
Gastric Mucosa / microbiology
-
Gastric Mucosa / pathology
-
Gastritis / drug therapy
-
Gastritis / microbiology*
-
Helicobacter Infections / complications*
-
Helicobacter Infections / drug therapy
-
Helicobacter pylori*
-
Humans
-
Lymphoma, B-Cell, Marginal Zone / drug therapy
-
Lymphoma, B-Cell, Marginal Zone / microbiology*
-
Lymphoma, B-Cell, Marginal Zone / pathology
-
Remission Induction
-
Stomach Neoplasms / drug therapy
-
Stomach Neoplasms / microbiology*
-
Stomach Neoplasms / pathology